Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals.
- Published In:
- Molecules (Basel, Switzerland), 23(10) (2018)
- Authors:
- Majkowska-Pilip, Agnieszka, Koźmiński, Przemysław, Wawrzynowska, Anna, Budlewski, Tadeusz, Kostkiewicz, Bogusław, Gniazdowska, Ewa
- Database ID:
- RPEP-03798
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03798APA
Majkowska-Pilip, Agnieszka; Koźmiński, Przemysław; Wawrzynowska, Anna; Budlewski, Tadeusz; Kostkiewicz, Bogusław; Gniazdowska, Ewa. (2018). Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals.. Molecules (Basel, Switzerland), 23(10). https://doi.org/10.3390/molecules23102542
MLA
Majkowska-Pilip, Agnieszka, et al. "Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals.." Molecules (Basel, 2018. https://doi.org/10.3390/molecules23102542
RethinkPeptides
RethinkPeptides Research Database. "Application of Neurokinin-1 Receptor in Targeted Strategies ..." RPEP-03798. Retrieved from https://rethinkpeptides.com/research/majkowska-pilip-2018-application-of-neurokinin1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.